Updates matching "Access to Biomarker Testing"

A new ACS CAN study released in the Journal of the American Medical Association (JAMA) finds many patients aren’t made aware of the importance of pharmacogenomic (PGx) testing. A form of biomarker testing, PGx testing examines how variations in a patient’s inherited genes may impact how they respond to different drugs and can improve the effectiveness of treatment and reduce the risk of adverse drug reactions.

Massachusetts cancer survivors and caregivers urge lawmakers to support legislation that will increase access to precision medicine and patient navigation for all communities.

As the largest coalition of Nebraska patients and provider groups in years to unite on a new health policy, we are glad to see that the Nebraska legislature recognizes the importance of biomarker testing and access to precision medicine.

Expanding access to this form of precision medicine will help more people in Connecticut get the right treatment at the right time.

Leading public health group urges Senate and Gov. Lamont to follow suit in ensuring biomarker testing can benefit more Connecticut patients

Leading public health group urges Senate and Gov. Lamont to follow suit in ensuring biomarker testing can benefit more Connecticut patients

RALEIGH, N.C. - More than 50 cancer advocates, including patients, survivors and caregivers from around North Carolina will travel to the General Assembly on Wednesday, April 16, to meet with lawmakers and ask for their support of House Bill 567 to increase access to biomarker testing. When someone

Maryland state lawmakers have released details on the agreed upon 2025-26 budget—the contents of which are a mixed bag in the fight against cancer. While the state made sound investments in cancer research and protected Medicaid recipients’ ability to access biomarker testing, it missed an opportunity to save the lives and lungs of Maryland’s youth by cutting funding for the state’s tobacco prevention and cessation programs.

North Carolina lawmakers have taken a critical step in efforts to reduce the cancer burden by introducing House Bill 567 . If passed, the legislation would allow more North Carolinians to access biomarker testing, which has become an increasingly important part of cancer care. Patients who are diagnosed with